Historical Valuation
Abivax SA (ABVX) is now in the Fair zone, suggesting that its current forward PS ratio of 295.08 is considered Fairly compared with the five-year average of -8.34. The fair price of Abivax SA (ABVX) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：115.49
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Abivax SA (ABVX) has a current Price-to-Book (P/B) ratio of 17.51. Compared to its 3-year average P/B ratio of -12.51 , the current P/B ratio is approximately -239.93% higher. Relative to its 5-year average P/B ratio of 0.11, the current P/B ratio is about 16250.25% higher. Abivax SA (ABVX) has a Forward Free Cash Flow (FCF) yield of approximately -1.92%. Compared to its 3-year average FCF yield of -19.62%, the current FCF yield is approximately -90.23% lower. Relative to its 5-year average FCF yield of -16.27% , the current FCF yield is about -88.22% lower.
P/B
Median3y
-12.51
Median5y
0.11
FCF Yield
Median3y
-19.62
Median5y
-16.27
Competitors Valuation Multiple
AI Analysis for ABVX
The average P/S ratio for ABVX competitors is 987.14, providing a benchmark for relative valuation. Abivax SA Corp (ABVX.O) exhibits a P/S ratio of 295.08, which is -70.11% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for ABVX
1Y
3Y
5Y
Market capitalization of ABVX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ABVX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ABVX currently overvalued or undervalued?
Abivax SA (ABVX) is now in the Fair zone, suggesting that its current forward PS ratio of 295.08 is considered Fairly compared with the five-year average of -8.34. The fair price of Abivax SA (ABVX) is between to according to relative valuation methord.
What is Abivax SA (ABVX) fair value?
ABVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Abivax SA (ABVX) is between to according to relative valuation methord.
How does ABVX's valuation metrics compare to the industry average?
The average P/S ratio for ABVX's competitors is 987.14, providing a benchmark for relative valuation. Abivax SA Corp (ABVX) exhibits a P/S ratio of 295.08, which is -70.11% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Abivax SA (ABVX) as of Jan 09 2026?
As of Jan 09 2026, Abivax SA (ABVX) has a P/B ratio of 17.51. This indicates that the market values ABVX at 17.51 times its book value.
What is the current FCF Yield for Abivax SA (ABVX) as of Jan 09 2026?
As of Jan 09 2026, Abivax SA (ABVX) has a FCF Yield of -1.92%. This means that for every dollar of Abivax SA’s market capitalization, the company generates -1.92 cents in free cash flow.
What is the current Forward P/E ratio for Abivax SA (ABVX) as of Jan 09 2026?
As of Jan 09 2026, Abivax SA (ABVX) has a Forward P/E ratio of -41.67. This means the market is willing to pay $-41.67 for every dollar of Abivax SA’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Abivax SA (ABVX) as of Jan 09 2026?
As of Jan 09 2026, Abivax SA (ABVX) has a Forward P/S ratio of 295.08. This means the market is valuing ABVX at $295.08 for every dollar of expected revenue over the next 12 months.